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ABSTRACT 
 We studied invasion-related adhesion events in vitro using three squamous 
carcinoma cell lines (HSC-3, poorly differentiated type; OSC-19, well- 
differentiated type; and KB cells, undifferentiated type).  In vitro invasion assay 
through matrigel in the transwell chamber revealed that HSC-3 cells were most 
invasive, OSC-19 cells  moderately invasive and KB cells least invasive.  By 
inhibition assay of invasion using synthetic peptides RGD, RGDV, RGDS, RGDT, 
IKVAV and YIGSR, invasion of three cell lines was significantly inhibited by 
RGDV.  There were another peptides which inhibited invasion significantly 
including IKVAV for HSC-3,  RGDS and YIGSR for OSC-19.  HSC-3 cells 
and OSC-19 cells adhered to fibronectin, laminin, vitronectin, and type IV 
collagen, and KB cells did not adhere to laminin but did to fibronectin, vitronectin 
and collagen type IV.  Pretreatment of cells with RGDV peptide in the 
attachment assay reduced binding ability of these cells to vitronectin and 
fibronectin more efficiently than pretreatment with RGDS.  Anti-αv antibodies 
inhibited adhesion of HSC-3, OSC-19 and KB cells to vitronectin, but anti-β1 
antibodies did not inhibit adhesion.  Immunofluorescent microscopic 
examinations showed that all cell lines were positive for anti-β5 and anti-αv 
antibodies, and only HSC-3 cells were positive for anti-β3 antibody. α5β1 was 
not clearly demonstrated in all cell lines.  RGDV was most effective inhibitor of 
squamous cell carcinoma invasion among synthetic oligopeptides used in this 
experiment, and it was suggested that it affected αvβ3 and/or αvβ5-mediated 
carcinoma cell invasion. 
 
 





 Attachment of carcinoma cells to the extracellular matrix (ECM) and the 
subsequent cellular movement are important steps for the cell invasion.  
Integrins which form a superfamily in compliance with a combination of subunits 
are cell surface receptor for ECM, and integrin expression is believed to affects 
adhesiveness of cells to ECM proteins and following migration (Ruoslahti and 
Giancotti 1989; Albelda 1993; Evans 1992).  Although a good correlation 
between integrin expression and tumor progression has been noted in melanoma 
cells and glial tumor cells (Cheresh 1991; Gladson and Cheresh 1991), the pattern 
of integrin expression on the other types of malignant tumors appears to be 
complicated (Korhonen et al. 1992, Miettinen et al. 1993), and there is no distinct 
aggreement to address which integrins are responsible for invasion and metastasis 
of tumor cells.   
    Synthetic peptide analogs of adhesive proteins have been used as 
potential blockers of distinct integrins in vitro and in vivo (Hirano et al. 1991; 
Kramer et al. 1986; Steiner et al. 1989; Chen et al. 1991).  Since the first 
demonstration by Pierschbacher and Ruoslahti (1984) of a recognition 
determinant on fibronectin for α5β1 consisting of the Arg-Gly-Asp (RGD) amino 
acid sequence, many studies have convinced that this sequence has been a 
minimal determinant of integrin recognition on many adhesive proteins, including 
fibronectin, vitronectin, collagen and laminin that bind to the β1, β3, β5 and β6 
family of integrins.  Although this observation was of fundamental importance, 
the RGD sequence alone cannot account for the specificity of integrins for 
adhesive proteins (Yamada 1991).  It has been reported that the activity of 
oligopeptides depends on X of RGDX sequence (Hirano et al. 1991; 
Pierschbacher and Ruoslahti 1984).  The determinants of adhesion proteins 
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responsible for integrin selectivity have been the subject of active investigation to 
address whether they are selective toward carcinoma cell integrins to inhibit 
invasion.    
 In the present study, we have examined inhibitory activity, specificity and 
selectivity of RGD(X) peptides encompassing the cell binding domains of 
fibronectin, vitronectin, collagen and laminin on squamous cell carcinoma 
invasion as well as synthetic peptides of non-integrin laminin receptors.  The 
expression of integrins and their involvement in the invasion was also examined 
and it has been suggested that αv integrins have been involved in invasion of 
squamous cell carcinomas. 
6 
MATERIALS  AND  METHODS 
Cell  culture 
 Established cell lines originating from human squamous cell carcinomas 
(OSC-19, HSC-3 and KB) were used.  OSC-19 cells are of well-differentiation 
(Yokoi et al. 1988) and provided by Dr. Kohama (Department of Maxillo-facial 
Surgery, Sapporo Medical College, Sapporo, Japan). HSC-3 cells of poorly-
differentiated type (Momose et al. 1989) and KB cells of undifferentiated type 
(Eagle 1955) were provided by Japanese Cancer Research Resource Bank.  KB 
cells have been reported to express HeLa cell marker (Nelson-Pees et al. 1974).  
Synthetic  peptides 
 Oligopeptides of Arg-Gly-Asp (RGD), Arg-Gly-Asp-Ser (RGDS) and Arg-
Gly-Glu-Ser (RGES) were purchased from Bachem Inc. (Torrance,  CA, USA), 
and Arg-Gly-Asp-Val (RGDV), Thr-Ile-Gly-Ser-Arg  (YIGSR)  and Arg-Gly-
Asp-Thr (RGDT) were from Peninsula Laboratories Inc. (Belmont, CA, USA).  
Ile-Lys-Val-Ala-Val (IKVAV) was synthesized by using an automated model 
431A synthesizer (Applied Biosystems, Foster city, CA, USA) followed by high 
performance liquid chromatography. 
 RGDS is a cell-binding site of fibronectin (Pierschbacher and Ruoslahti 
1984), YIGSR of laminin B1 chain (Graf et al. 1987), IKVAV of laminin A chain 
(Tashiro et al. 1989), RGDV of vitronectin (Suzuki et al. 1985), and RGDT of 
collagen (Pierschbacher and Ruoslahti 1984).  RGD is a minimum adhesion 
peptide sequence existed in many adhesive ligands for integrins, and RGES is 
used as a control oligopeptide with no binding activity. 
Invasion assay 
 The invasiveness of cell lines was measured by using transwell chamber of 
12 µm pores (Coaster, Cambridge, MA, USA) coated with reconstituted basement 
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membrane matrigel which contained laminin, collagen type IV, vitronectin, 
heparan sulfate proteoglycan and entactin as previously described (Kramer et al. 
1986; Seftor et al. 1992) with some modification.   Reconstituted basement 
membrane was prepared with 500 mg/ml of matrigel diluted in Eagle's minimum 
essential medium (MEM, Flow Laboratories, Irvine, Scottland) containing 10% 
fetal bovine serum.  Matrigel (150 mg) was solidated by air-dry in room 
temperature under sterile condition and subsequently 400 ml of the medium was 
added on the upper chamber.  Carcinoma cells at a  concentration of 2×105 
cells/ chamber were overlaid on matrigel, and 0.6 µmol of oligopeptides was 
added in the upper chamber.  The lower chamber was filled with 1.5 ml of the 
medium.   After incubation for 17 hr at 37ﾟC in a CO2 incubator, invading cells 
through matrigel into the lower chamber were collected and centrifuged at 5,000 
rpm for 4 min using a microtest tube.  Cells attached on the wall and roof of the 
lower chamber were also collected by trypsinization.  The numbers of invaded 
cells were counted by fluorometric assay (Huschtscha et al. 1989).  The 
significance of difference of inhibition was determined by one way analysis of 
variance and followed by contrast statements using Statistical Analysis System. 
Fluorometric  assay 
 Each cell sample was washed twice with PBS, pH 7.4, suspended in freshly 
prepared 2 ml of fluorometric assay solution containing 1.2 mM 4-
methylumbelliferyl phosphate (Sigma, St. Louis, MO, USA), 1 mM MgCl2, and 
0.2 mM boric acid, and incubated for 3 hr at 37ﾟC.  The relative fluorescence of 
4-methylumbelliferone was measured using a Fluorescence Electrophotometer 
850 (Hitachi, Tokyo, Japan).  The wavelength of the excitation and the emission 
were 345 and 447 nm, respectively.  The numbers of cells in the lower chamber 
without supplement of synthetic peptides in this invasion assay were regarded as 
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100% of invasion and the proportions of invaders treated with the peptides were 
determined. 
Cell attachment assay 
 The attachment assay was performed as previously described elsewhere 
(Leaversley et al. 1992).  Briefly, flat-bottomed plates (3042 Micro Test I, 
Falcon Products, Oxnard, CA, USA) were coated with 10 mg/ml of laminin, 
vitronectin, fibronectin, collagen type I and IV, and BSA overnight at 4ﾟC.  
Each substrate was purified as previously described; that is,  vitronectin and 
fibronectin were from human plasma (Yatohgo et al. 1988; Kawahara et al. 1989) 
collagen type I and IV  from human placenta (Ueda et al. 1989; Minamoto et al. 
1988) and mouse laminin were isolated from Engelbreth-Holm-Swarm tumor 
(Kleinman et al. 1982)  1×105 cells with triplicates were added in 5% BSA in 
serum-free medium (MEM) and incubated until 4 hr at 37ﾟC to allow the cells to 
attach on the substrate.  To count the number of attached cells, the MTT assay 
(Mosmann 1983) performed.  After removing non-attached cells by washing, the 
plates were filled with 100 ml the  medium and 10 ml 3-(4, 5-dimethylthiazol-2-
yl)-2, 5-diphenyltetrazolium bromide (MTT, Sigma, St. Louis, MO, USA) 
solution (5 mg/ml in PBS), then incubated for 4 hr at 37ﾟC.  At the end of the 
enzymatic reaction the insoluble dye product was solubilized with of 
dimethylsulphoxide with mixing thoroughly.  Subsequently, the absorbance at 
492 nm was read with EIA Reader 2550 (Bio-Rad Lab., Richmond, CA, USA). 
Antibodies 
 Anti-α2β1, α3β1 and α5β1 monoclonal antibodies were purchased from 
DAKO corporation (USA), and anti-vitronectin receptor (αv) polyclonal 
antibodies were purchased from Telios Pharmaceuticals (LaJolla, CA, USA).  
Anti-αvβ3 polyclonal antibodies were kindly provided by Dr. B. Vogel, anti-β3 
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antibody (AP3) by Dr. P. Newmann, and anti-β5 antibody (IVF2) by Dr. M. 
Hemler (Pasqualini et al. 1993).
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Immunoprecipitation of integrins 
 Cell surface proteins were iodinized with 125I using lactoperoxidase 
(Sonnenberg et al. 1987). 125I-labeled cells were homogenized in 25 mM Tris-
HCl buffer, 2% NP-40, 100mM NaCl, CaCl2, pH 7.6, containing 1 mM 
diisopropylfluorophosphate, 2 mM phenylmethyl-sulphonyl fluoride, 10 mM 6-
amino-n-caproic acid, 1 µg/ml leupeptin, 1 mM n-ethyl-maleimide, and 10 µg/ml 
aprotinin at room temperature, and the supernatant was incubated with polyclonal 
anti-αvβ3 antibodies for 1 hr at 4℃.  The solution was applied to protein G- 
Sepharose (Pharmacia-LKB, Uppsala, Sweden).   The immunocomplexes bound 
with protein G were eluted by 0.1 M glycine-HCl, and run in SDS-PAGE (7.5%) 
under non-reducing condition.  The electrophoresed 125I-labeled proteins were 
visualized by autoradiography with preflashed X-Omat AR films (Eastman Kodak 
Co. Rochester, NY). 
Immunofluorescent microscopy 
 Cells (0.6×104 cells/ ml) in serum-free medium were plated on slide glasses 
coated with purified human fibronectin and vitronectin, collagen and laminin (10 
mg/ml), and incubated for 2 hr and 17 hr.  Attached cells were fixed with 1% 
paraformaldehyde for 3 min at room temperature. The cells were reacted with 
primary antibodies to integrins for 60 min at room temperature.  FITC-
conjugated secondary antibodies were added  and incubated for 60 min at room 
temperature.  As a negative control mouse Ig G was substituted for a primary 
antibody.  The dilutions of monoclonal anti-α2β1, -α3β1, -α5β1, -β3 and -β5 
antibodies and polyclonal anti-αv antibodies were 500, 500, 500, 1,000 and 1,000, 
respectively.  The dilutions of FITC-conjugated anti-mouse Ig G antibodies and 
anti-rabbit Ig G antibodies (Cappel, West Chester, PA, USA) were 20.   
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RESULTS 
Content of vitronectin and fibronectin in the present invasion assay 
 Seftor et al. (1992) first reported the presence of vitronectin in matrigel (25 
mg/ml) using immunoblotting examination.  We also confirmed the presence of 
vitronectin in matrigel (18 mg/ml) by immunoblotting and sandwich ELISA 
method.  Fibronectin was not detected in matrigel.  But, fibronectin derived 
from FBS added in the matrigel dilution should be contained in reconstituted 
basement membrane.  Production of fibronectin from OSC-19 cells in plastic 
dishes, but not from HSC-3 cells, was apparently observed by immunoblotting.  
Vitronectin derived from those cells were not detected (data not shown). 
Invasiveness of cells through reconstituted basement membrane 
 Our preliminary invasion assay on time course (4, 8, 16 and 24 hr) showed 
that the number of invaded OSC-19 cells traversing through the entire thickness 
of matrigel increased rapidly within 16 hr followed by gradual increase until 24hr, 
and then we chose the 17 hr assay.  Since the present invasion assay system 
could be influenced by cell densities on culture dishes, probably resulting from 
alteration of integrin expression (Larjava 1990), we checked the density of OSC-
19 cells on plastic culture dishes adequate for the invasion assay.  Cells cultured 
in a sparse density (6,000±3,000 cells/cm2) invaded most actively (11,000±
2,100 cells).  The number and its standard deviation of invaded cells when were 
cultured subconfluently (45,000±7,000 cells/cm2) was 9,400±2,700, and that 
when cultured confluently (75,000±10,000 cells/cm2) was 6,400±2,400.  Then, 
we chose the sparse cell density for the present in vitro invasion assay.  First we 
examined the invasiveness, and the  result showed that HSC-3 cells were most 
invasive (41,000±11,000 cells), OSC-19 cells were less invasive (11,000±2,000 
cells) and KB cells were the least (7,800±3,000 cells). 
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Inhibition of invasion by synthetic peptides 
 We examined the dose dependent inhibitory effect of peptides, using RGDS 
on OSC-19 cell invasion (Figure 1).  Since 0.3 µmol/ chamber of RGDS 
inhibited the invasion, we used that amount for all peptides.  Inhibitory effects of 
these peptides used were shown in Figure 2.   The significant difference of those 
inhibition were determined by being compared with those of RGES peptide.  
RGDS showed a significant inhibition effect on OSC-19 cells.  Laminin-derived 
YIGSR peptide significantly suppressed invasion of OSC-19 cells.  Distinct 
laminin-derived IKVAV peptide significantly inhibited the invasion of HSC-3 
cells, but not that of OSC-19 cells.  Vitronectin-derived RGDV peptide showed 
significant inhibitory effects on all cell lines examined.  RGDT sequence within 
collagen did not inhibit apparently invasion of all cell lines.  RGD peptide, 
which does not function alone and is plausible to lack information determining 
receptor specificity (Yamada 1991), did not influence the invasion of OSC-19, 
HSC-3 and KB cells. 
Attachment to extracellular matrix proteins 
 We examined the ability of cells to attach to purified intact proteins, 
fibronectin, laminin, vitronectin, collagen type IV which are involved in the 
invasion assay system (Figure 3).  All cell lines were adhered promptly to 
fibronectin and collagen type IV within 1 hr.  All cells showed time lag for 
adhesion to vitronectin, and OSC-19 cells and HSC-3 cells also showed delayed 
adhesion to laminin.  KB cells were not adhered to laminin.  This could be the 
reason why KB cells were not inhibited by laminin-derived peptides of IKVAV 
and YIGSR.  To clarify the inhibitory effect of RGDV peptide on cell 
attachment, the other attachment inhibition assay has been done as follows; 
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culture cells which were pretreated with RGDV or RGDS peptide were placed on 
vitronectin or fibronectin, followed by attachment assay for 2 hr.  The result 
showed both peptides inhibited attachment of cells to vitronectin, and RGDV 
inhibited it more efficiently than RGDS.  RGDV also inhibited the attachment to 
fibronectin, although it was less effective than the attachment to vitronectin (Fig. 
4).  This indicates that RGDV inhibits chiefly attachment of cells to vitronectin 
which has RGDV sequences.  Thus, it is suspected that vitronectin receptors of 
αv integrins would be involved in the inhibitory effect of RGDV on the cellular 
attachment and invasion.  Nextly, we performed the inhibition assay of the 
attachment using anti-αv integrins to clarify the implication of αv integrins in 
attachment of the cells to vitronectin.  The result showed that anti-αv antibodies 
inhibited the attachment of all cell lines to vitronectin, whereas anti-β1 integrin 
antibodies did not (Fig. 5). 
Integrin expression 
 125I-surface labeling and immunoprecipitation by polyclonal anti-αvβ3 
antibodies showed that two bands of Mr 160 and 95 kDa in HSC-3 cells 
indicating αv and β3, respectively, and a single band of 160 kDa in OSC-19 cells 
indicating αv.  We further investigated expression of integrins on vitronectin, 
fibronectin, laminin and collagen type IV, at 2 hr after incubation when all cells 
are supposed to attach to ligands except for KB cells on laminin by 
immunofluorescent microscopy (Fig. 6).  β5 and αv were detected in all cell 
lines.  β3 was detected only in HSC-3 cells.  Their staining patterns were 
diffuse and there was no preferential localization on cell membranes.  All cell 
lines were also positive for anti-α2β1 and α3β1 antibodies.  α5β1 integrin was 




 Integrins play a key role in cell-matrix interaction in physiological conditions, 
and it has been reported that with malignant transformation certain type of 
integrin were upregulated and involved in tumor progression and metastasis 
(Ruoslahti and Giancotti 1989; Albelda 1993; Evans 1992).  In the present study, 
we examined the correlation between invasiveness and adhesiveness of three 
squamous carcinoma cell lines with a particular attention to the inhibitory effect 
of adhesion oligopeptides on the invasion model.  First, we checked three 
different cell lines in terms of invasiveness using an in vitro invasion assay 
system which have become a useful tool for evaluating cancer invasion.  In fact 
there were many reports that have substantiated positive correlation of the 
invasive properties with the ability of cells to invade matrigel (Kramer et al. 1986; 
Albini et al. 1984; Parish et al. 1992).  In the present invasion study, HSC-3 cells 
and OSC-19 cells were invasive, and KB cells were less invasive.  Previously, 
Kawahara et al. (1993) examined comparatively OSC-19 and KB cells, and 
showed that OSC-19 cells of infiltrating into the subcutaneous tissue of nude mice 
were able to invade into collagen gel, while KB cells growing expandingly in 
nude mice were not capable of infiltrating in the gel.  Such a difference of 
invasiveness may correlate to some extent with cell-matrix interaction through 
cell adhesion molecules, because in the attachment assay KB cells were 
specifically not adhere to laminin and anti-αv integrin antibody inhibited the 
attachment of cells to vitroenctin. 
 Secondly, we could demonstrated in the competitive inhibition assay using 
different synthetic peptides that three different cell lines were commonly 
suppressed the penetration through matrigel only by RGDV, vitronectin-derived 
15 
tetrapeptide.  Tetrapeptides we used, RGDV, RGDS and RGDT seem to inhibit 
binding to all RGD-dependent integrins non-specifically, as RGDS inhibits the 
attachment of the cells to RGD-containing matrix proteins, vitronectin, 
fibronectin and fibrinogen (Hirano et al. 1991).  In general, RGD-containing 
oligopeptides, however, show distinct effect on perturbing cell-matrix interaction 
(Hirano et al. 1991; Kouns et al. 1992; Chen and Hawiger 1991) depending on X 
of RGDX (Hirano et al. 1991; Pierscbacher and Ruoslahti 1984).  RGDS, RGDV, 
RGDF, RGDT, and RGDA are known to be active (Hirano et al. 1991).  
Scarborough et al. (1993) clarified that disintegrins containing RGDW sequences 
were specific for integrin αIIbβ3 and RGDNP-containing disintegrins were 
specific for integrin αvβ3.  The longer sequences of fibronectin containing a 
RGD sequence has the higher affinity to α5β1, although an RGD peptide has little 
activity (Pierscbacher and Ruoslahti 1984).  These data indicate that certain 
amino acid sequences have strong affinity to the corresponding integrins.  
Actually, in our study RGDV was the most effective peptide that inhibits 
competitively cell invasion and attachment, suggesting that valine following 
aspartic acid would be crucial in the present cell-matrix attachment event of 
squamous carcinoma cells.  The presence of RGDV might perturb αv integrin 
expression; αvβ5 in OSC-19 and KB cells, and αvβ5 and αvβ3 in HSC-19 cells.  
Our inhibition data of the attachment assay confirmed that RGDV rather than 
RGDS clearly reduced cell attachment to vitronectin.  Furthermore, the 
attachment of these cell lines to vitronectin was inhibited by anti-αv integrin 
antibodies.  These phenomena remind us that cells adhere to vitronectin by using 
αv- integrins, as is known well that receptors for vitronectin are exclusively αv 
integrins of αvβ1 (Zhang et al. 1993), αvβ3, αvβ5 (Smith et al. 1990) and αvβ8 
(Moyle et al. 1991) in a RGD-dependent manner besides αIIbβ3 of the platelet 
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integrin (Kouns et al. 1992).  RGDV peptide which is the selective sequence of 
vitronectin would result in having more avidity to αv-integrins than RGDS does.  
Thus, it is presumed that RGDV inhibits the invasive ability by interfering the 
attachment of αv-integrins to macromolecules, particularly vitronectin.  The 
importance of αv integrins would not be a universal phenomenon in malignant 
tumors, because a variety of malignant tumors show distinct integrin patterns 
reflecting the expansion of original cells (Korhonen et al. 1992; Miettinen et al. 
1993).  However, it is important to remind that αvβ5 integrin was originally 
discovered from epithelial cell-derived carcinoma cells (Smith et al. 1990), and 
normal keratinocytes have αvβ5 (Marchisio et al. 1991; Adams and Watt 1991).   
 There are many reports on the role of αv integrin in melanoma cell 
invasiveness.  For example, in melanoma cells a stable transfection of a cDNA 
encoding αv integrin subunit resulted in a dramatic increased tumorigenicity 
(Felding-Habermann et al. 1992) and αvβ3 integrin expression is linked to the 
tumor progression (Cheresh 1991; Nip et al. 1992) and melanoma cell migration 
(Leaversely et al. 1992).  In carcinoma, renal cell carcinomas which express αv-
integrins have worse prognosis (Korhonen et al. 1992).  These facts imply that 
the phenotype with this integrin may be responsible for a wide range of migratory 
and invasive event of cells.  As shown in the present study, αvβ3 and/or αvβ5 
particularly recognized in HSC-3 cells could contribute to the invasive property 
  Both  HSC-3 and OSC-19 cells, whose invasion was inhibited by laminin-
derived peptides, IKVAV or YIGSR, adhered well to laminin. YIGSR has been 
reported to enhance metastasis (Graf et al. 1987; Iwamoto et al. 1987).  IKVAV 
also has been said to have an important role in invasion (Tashiro et al. 1989).  In 
the present assay, IKVAV for HSC-3 and YIGSR for OSC-19 were inhibitory 
peptides.  KB cells which did not attach to laminin were not inhibited by 
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IKVAV and YIGSR.  Cell adhesion molecules to laminin are α6β1, α6β4, 
YIGSR receptor and IKVAV receptor.  Thus, it is reasonable to think that 
invasiveness of squamous carcinoma cell lines is partly regulated by αv-integrin 
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FIGURE  LEGEND 
Fig. 1. Dose dependent inhibitory effect of RGDS oligopeptides on OSC-19 cell 
invasion.  
Fig. 2. Inhibitory effects of oligopeptides on carcinoma cell invasion through 
matrigel.  Cells were treated with 0.3 µmol/ chamber of peptides.  Invasion of 
three cell lines is commonly inhibited by RGDV.  Asterisk stands for significant 
inhibition in comparison with RGES (P<0.05).  Each bar represents the mean±
the standard error of triplicates. 
Fig. 3. Time course of attachment assay.  OSC-19 cells (A), HSC-3 cells (B) and 
KB cells (C) adhere to collagen type IV ( ●) and fibronectin (○)rapidly.  All 
cells adhere well to vitronectin (■) but there is time lag in comparison with 
adhesion to collagen and fibronectin (A, B, C).  OSC-19 cells and HSC-3 cells 
adhere to laminin (□) in a similar fashion to vitronectin (A, B).  KB cells do not 
adhere to laminin (C). Each point represents the mean±the standard error of 
tiplicates. 
Fig. 4. Inhibitory effects of RGDS and RGDV peptides on cell attachment assay 
to fibronectin and vitronectin.  Cells (1×105 cells/ well) were pretreated with 
synthetic peptides (0.3 µmol/well) for 60 min, incubated on each substrate for 2hr.  
RGDV inhibits more efficiently than RGDS in the attachment of cells to 
vitronectin and fibronectin.  The data shown in this figure are the mean values 
(±the standard deviation) of triplicate determinations. 
Fig. 5. Inhibitory effects of antibodies on attachment of carcinoma cells to 
vitronectin.  Three cell lines are all inhibited by polyclonal anti-αv integrin 
antibodies, and not inhibited by polyclonal anti-β1 antibodies. Each bar represents 
the mean±the standard error of triplicates. 
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Fig. 6. Immunoprecipitation of integrins subunits expressed on carcinoma cell 
lines. Lysates of 125I-surface labeled OSC-19 (lane 1) and HSC-3 cells (lane 2) 
were immunoprecipitated with polyclonal anti-αvβ3 antibodies.  
Immunoprecipitated samples were separated SDS-PAGE (7.5% acrylamide) in 
non-reducing condition, and the bands were visualized by autoradiography.  
Molecular markers are indicated on the left. 
Fig. 7. Immunofluorescent microscopic demonstration of integrin β5 (A, E), β3 
(B, F), α3β1 (C, G) and α5 (D, H) in HSC-3 cells (A-D) and OSC-19 cells (E-H).  
Cells were cultured for 2 hr in serum-free medium on vitronectin (A, B, E, F), 
fibronectin (C, G) and type IV collagen (D, H).  β5 is positive in HSC-cells in a 
dot-like or fibrillar pattern, and OSC-19 cells in a diffuse or fibrillar pattern.  β3 
was positive in HSC-3 cells, but not in OSC-19 cells.  α3β1 is positive in HSC-3 
and OSC-19 cells.  Clear positivity for α5β1 is not shown in HSC-3 and OSC-19 
cells. 
